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MaOBJECTIVES The aim of this study was to analyze the change of upper limb function when percutaneous coronary
procedures were performed through the radial artery.
BACKGROUND It is currently unknown if upper limb function is affected by transradial (TR) catheterization.
METHODS Between January 2013 and February 2014, upper limb function was assessed in a total of 338 patients
undergoing coronary catheterization in an ambulatory setting (85% radial approach, 15% femoral approach). Upper limb
function was assessed with the self-reported shortened version of the Disabilities of Arm, Shoulder, and Hand
questionnaire. The presence and severity of upper extremity cold intolerance was assessed with the self-reported Cold
Intolerance Symptom Severity questionnaire. Both questionnaires were completed before the catheterization and at
30-day follow-up. Higher scores represent worse upper limb functionality or symptoms. The nonparametric Wilcoxon
signed-rank test was used to assess the change of upper limb function and symptoms over time.
RESULTS Upper limb function did not change signiﬁcantly over time when catheterization was performed through the
radial artery (p ¼ 0.06). The number of procedure-related extremity complaints that persisted during 30-day follow-up
were not different between both access groups (TR access 10.5%, transfemoral access 11.5%; p ¼ 0.82). The upper
extremity was not affected by cold intolerance after TR access at 30-day follow-up (p ¼ 0.91).
CONCLUSIONS Upper limb function was not affected when coronary catheterizations and interventions were
performed through the radial artery. (J Am Coll Cardiol Intv 2015;8:515–23) © 2015 by the American College of
Cardiology Foundation.C oronary catheterization is regularly per-formed to diagnose or treat coronary arterydisease (1,2). The femoral artery has been
the default access site for many years. Currently,
the radial artery is the preferred access route for
catheterization, mainly driven by the lower num-
ber of access (site)-related complications (3). Transra-
dial (TR) access is also considered to be a more
patient-friendly approach. Early mobilization with
signiﬁcantly less discomfort may improve quality of
life and shorten hospital length of stay (4).
These beneﬁts have led to the progressive adoption
of TR access and have brought attention to its
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collateral circulation of the hand (8). However, it has
been reported that radial artery occlusion may
become symptomatic in 50% to 60% of all cases (7,9).
This is supported by perfusion changes of the upper
extremity after radial artery harvesting under condi-
tions of stress (10,11). It appears that inadequate
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516occlusion, albeit at a relatively low rate. In
addition, a signiﬁcant amount of vascular
damage and chronic intimal thickening is
induced by TR interventions (13) with lumen
narrowing and endothelial dysfunction,
which may jeopardize upper limb function as
well (14,15). Other factors that may impair
upper limb function are nerve injury, granu-
lomas, and pseudoaneurysms. Apart from
mere discomfort, this might have consider-
able implications for those patients for whomoptimal upper extremity function is paramount. We,
therefore, sought to determine the self-reported
change in upper limb function after TR coronary
catheterization.SEE PAGE 524METHODS
STUDY DESIGN. ACRA (Assessment of disability after
Coronary procedures using Radial Access) is a pro-
spective, 2-center study designed to evaluate the
effect of TR coronary catheterization on upper limb
function. A total of 1,212 elective percutaneous coro-
nary procedures were performed between JanuaryE 1 Enrollment Flowchart of the Study Population
follow-up; pts ¼ patients; TF ¼ transfemoral; TR ¼ transradial.2013 and February 2014 in 2 academic institutions.
Both institutions are high-volume tertiary referral
centers that are located in 2 large cities in the
Netherlands.
After informed consent was obtained, each patient
completed 2 different hand function–related ques-
tionnaires during ambulatory day care admission.
The results of the questionnaires were unknown
to the treating physician and did not inﬂuence
the choice of vascular access. The study protocol
was approved by the local ethics committee and
was performed in accordance with the Declaration
of Helsinki. Exclusion criteria were: 1) inability to
read or not willing to answer the questionnaires;
2) ST-segment elevation myocardial infarction; and
3) hemodynamic instability. The enrollment ﬂow-
chart of the study is shown in Figure 1. Between
January 2013 and February 2014, a total of 338 pa-
tients with complete follow-up were included in the
present study (TR access: n ¼ 286). Follow-up was
incomplete or missing in 14 patients: 2 died before
30-day follow-up; 2 refused further participation;
and the remaining patients had incorrect contact in-
formation. Before the study was initiated, we per-
formed a power calculation. Based on a type I error of
5% and a power of 80%, assuming a QuickDASH
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517difference of 2.5 and an SD of 15, we needed 285
analyzable patients with TR access and complete
follow-up. We stopped inclusion when this number
was reached. The type of vascular access was left to
the operator’s discretion and was not mandated by
the study, resulting in 52 analyzable patients with
transfemoral (TF) access.
CORONARY CATHETERIZATION AND INTERVENTION.
The access site for coronary angiography or percu-
taneous coronary intervention (PCI) was according to
the preference of the treating cardiologist. Institu-
tion A performed TR access with a bare-needle
technique, and institution B used a venous cannula
technique. Both centers cannulated preferably the
right radial artery with a 6-F, 10-cm-long sheath
(Terumo, Somerset, New Jersey), and a cocktail of
0.2 mg nitroglycerine and 5 mg verapamil was given
intra-arterially. In case of coronary angiography a
standard dose of 5,000 IU of unfractionated heparin
was given intra-arterially, and when a PCI was per-
formed, the amount of unfractionated heparin was
adapted to the patient’s body weight. At the end of
the procedure, the sheath was removed, and a TR
band was applied (18-ml TR band, Terumo) for 4 h.
In case of TF access, a standard 6-F 10-cm-long
sheath (Terumo) was used. A collagen plug device
(Angio-seal, St. Jude Medical, St. Paul, Minnesota)
was applied at the end of the procedure.
UPPER LIMB FUNCTION AND SYMPTOMS. The Quick-
DASH questionnaire, a shortened version of the
Disabilities of the Arm, Shoulder and Hand (DASH)
questionnaire (16), was used to assess upper limb
function at 2 time points (before and 30 days after
catheterization).
Compared with the DASH questionnaire, Quick-
DASH enables faster measurement while maintaining
its internal consistency and inter-rater reliability
(Cronbach’s alpha of 0.92 and an intraclass correla-
tion coefﬁcient of 0.94) (17). QuickDASH has been
validated in a normative population and a variety of
conditions and is completed more often than the
DASH questionnaire (18). QuickDASH consists of 11
items to measure physical function, symptoms, and
its consequences on daily life, scored from 1 to 5.
At least 10 of the 11 items must be completed for a
score to be calculated. The assigned values for
all completed responses are averaged and then
transformed to a score from 0 to 100 by subtracting
1 from the average score and multiplying this by 25.
A higher score indicates greater upper extremity
disability. The minimal clinically-important differ-
ence (MCID) score that would correspond to a change
in clinical status appreciated by the patient (19)varies between 8 (20) and 14 (21) points for the
QuickDASH questionnaire.
Cold Intolerance Symptom Severity (CISS) is a
validated questionnaire to detect the occurrence of
cold intolerance (22). Cold intolerance is deﬁned as
abnormal pain of the hand and ﬁngers after exposure
to mild or moderate cold. It is associated with
signiﬁcant functional impairment and reduced
health-related quality-of-life, and it may seriously
inﬂuence patients’ daily life (23). It is a common
consequence of a variety of diseases and injuries of
the upper extremity, especially when neurovascular
structures are involved (24–26). The CISS question-
naire consists of 6 questions that have been validated
in a variety of upper extremity injuries (26) and a
normative control group (27). Based on the range of
normative values, a patient with a score of 30 or
higher has pathological cold tolerance (27). In this
study, we used the Dutch version of the QuickDASH
(28) and CISS (27).
At 30-day follow-up, patients were asked to
describe any procedure-related extremity complaints
or loss of function.
DATA COLLECTION. Clinical and procedural charac-
teristics were recorded and were prospectively
entered into a dedicated electronic database. Before
each procedure, capillary reﬁll, pulsations (good,
moderate, poor, or no), and vascular communication
were assessed by a trained research nurse or physi-
cian assistant. Vascular communication was tested
with the Allen test (29) in institution A and by
plethysmography (Barbeau test) (30) in institution B.
The Allen test was deﬁned as abnormal if the maximal
palmar blush was achieved 10 s after compression
release. Plethysmography was recorded at the thumb
before and immediately after radial artery compres-
sion and was divided into 4 types (A to D) as previ-
ously described (30). The reverse Barbeau test (with
compression of the ulnar artery) was performed
before discharge to test the vascular patency of the
radial artery (31). We considered the (reverse) Bar-
beau test to be abnormal in case of type C and D,
representing suboptimal (collateral) or no blood
supply to the thumb. Capillary reﬁll was deﬁned as
abnormal when it took >2 s for color to return to the
nail bed after pressure removal.
The occurrence of clinical radial artery spasm
(RAS) was evaluated during the procedure. RAS was
deﬁned as persistent forearm pain, pain response to
catheter manipulation, pain response to sheath
withdrawal, difﬁcult catheter manipulation after
being “trapped” by radial artery, and considerable
resistance on withdrawal of the sheath. Patients





(n ¼ 52) p Value
Demographic characteristics
Age, yrs 64  9 64  10 0.95
Male 207 (72) 36 (69) 0.64
Cardiovascular history
Previous MI 78 (27) 21 (40) 0.06
Previous CABG 9 (3) 14 (27) <0.01
Previous PCI 93 (33) 22 (42) 0.17
Peripheral artery disease 16 (6) 8 (15) 0.01
Previous radial access 120 (42) 23 (44) 0.76
Previous femoral access 95 (33) 27 (52) 0.01
Cardiovascular risk factors
Current smoking 52 (18) 5 (10) 0.13
Hypertension 155 (54) 28 (54) 0.96
Hypercholesterolemia 117 (41) 30 (58) 0.03
DM 35 (12) 7 (14) 0.81
BMI, kg/m2 28  4 27  4 0.17
Indication procedure
Stable CAD 248 (89) 43 (83) 0.44
Medication
Aspirin 223 (78) 42 (81) 0.65
P2Y12 inhibitor 135 (47) 32 (62) 0.06
Oral anticoagulant 39 (14) 5 (10) 0.43
ACE inhibitor/AT II antagonist 165 (58) 33 (64) 0.44
Beta-blocker 192 (67) 38 (73) 0.40
Statin 226 (79) 39 (75) 0.52
Nitrate 100 (35) 18 (35) 0.96
Diuretic 64 (22) 9 (17) 0.41
Calcium-channel blocker 85 (30) 15 (29) 0.90
Procedure
SBP, mm Hg 139  22 134  19 0.09
DBP, mm Hg 77  11 76  11 0.91
PCI 178 (62) 34 (65) 0.67
Procedural time (min) 48 (30) 64 (30) <0.01
Procedural success 270 (94) 48 (92) 0.56
RAS 31 (11)
Complicated procedure 8 (3) 2 (4) 0.68
Total heparin dose, IE 5,437 (1,644) 5,673 (2,806) 0.40
Pain score, VAS 3 (2) 2 (3) 0.27
Values are mean  SD or n (%). Complicated procedure was deﬁned and reported
by the operator. Independent-samples t test. p < 0.05 was considered statistically
signiﬁcant.
ACE ¼ angiotensin-converting enzyme; AT ¼ angiotensin; BMI ¼ body mass
index; CABG ¼ coronary artery bypass graft surgery; CAD ¼ coronary artery
disease; DBP ¼ diastolic blood pressure; DM ¼ diabetes mellitus; MI ¼ myocardial
infarction; PCI ¼ percutaneous coronary intervention; RAS ¼ clinical radial artery
spasm; SBP ¼ systolic blood pressure; VAS ¼ visual analogue scale.
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518who had at least 2 of 5 signs were diagnosed with
RAS (32). The amount of self-reported pain was
measured by the visual analog scale from 0 to 10
(“no pain at all” was scored as 0 and “unbearable
pain” as 10) at the end of the procedure and before
discharge. The pain score was considered to be
abnormal in case of moderate to severe pain (visual
analog scale >5).
ENDPOINTS. The primary endpoint was deﬁned as
the change in upper extremity function from baseline
to 30-day follow-up, as assessed by the QuickDASH
score. The change in cold intolerance, as assessed
by the CISS score, and the occurrence of other
procedure-related symptoms were considered to be
secondary endpoints.
STATISTICAL ANALYSIS. Continuous variables are
presented as mean  SD, and categorical variables
are expressed as percentages. Comparisons among
clinical and procedural characteristics in patients
undergoing TR or TF access were performed using
Pearson’s chi-square test for categorical variables
and independent-samples t test for continuous var-
iables. The Kolmogorov-Smirnov test was used to
check for a normal distribution of the variables in
our study population. The nonparametric Wilcoxon
signed rank test was used to assess the change of
upper extremity function and cold intolerance over
time. The Mann-Whitney U test was used to compare
the QuickDASH and CISS scores (nonparametric
continuous variables). Logistic regression analyses
were applied to test the relation between the applied
access route and the development of cold intoler-
ance or loss of upper extremity function. Logistic
regression analyses were also used to test the asso-
ciation between vascular communication or patency
and clinically-relevant loss of upper extremity
function or the development of pathological cold
intolerance.
All statistical tests were 2-tailed, and a p value<0.05
was considered statistically signiﬁcant. All statistical
analyses were performed with SPSS for Windows
version 22.0 (SPSS, Inc., Chicago, Illinois).
RESULTS
STUDY POPULATION. A total of 352 patients were
prospectively enrolled between January 2013 and
February 2014. Complete 30-day follow-up was pre-
sent in 338 patients, and TR access was applied in
85% (n ¼ 286). The mean age of the study population
was 64 years, and 72% of the population was male.
Clinical and procedural characteristics are pre-
sented in Table 1. Patients undergoing procedureswith femoral access more often had prior coronary
artery bypass graft surgery and longer procedures. All
other characteristics were the same for both access
routes. RAS occurred in 11% of all TR procedures.
UPPER LIMB FUNCTION AND SYMPTOMS. At base-
line, QuickDASH scores were signiﬁcantly higher
in female and elderly patients (age $75 years),
representing a worse upper extremity function. The
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519median QuickDASH scores were 2.27 (interquartile
range [IQR]: 0.00 to 11.36) for male and 9.09 (IQR: 2.27
to 25.00) for female patients (p < 0.001) and were
9.09 (IQR: 2.27 to 18.18) for elderly patients and 2.39
(IQR: 0.00 to 13.64) for patients age <75 years
(p ¼ 0.015). The QuickDASH score was not different
for both access groups (p ¼ 0.28).
Figure 2A shows QuickDASH scores at baseline and
follow-up. No signiﬁcant change in upper limb func-
tion could be observed when coronary procedures
were performed through the radial artery (baseline
4.55 [IQR: 0.00 to 13.64]; follow-up 2.27 [IQR: 0.00 to
9.32]). Similarly, no change in upper limb function
was reported when patients were treated via the
femoral artery (baseline 6.82 [IQR: 0.00 to 17.61];
follow-up 5.68 [IQR: 0.00 to 13.64). The change in
QuickDASH score was distributed the same across
both access groups (p ¼ 0.95). These ﬁndings under-
score the fact that access strategy did not affect post-
procedural upper limb function. The applied TR
access technique was not associated with an in-
creased QuickDASH score (hazard ratio: 1.32, 95%
conﬁdence interval: 0.71 to 2.45; p ¼ 0.38).
Figure 3A stratiﬁes the percentage of TR patients
with increased, decreased, or unchanged QuickDASH
scores. When treated through the radial artery,
73 patients (25.5%) had increased QuickDASH scores,FIGURE 2 Effect of Catheterization on Upper Limb Function and Co
(A) Upper limb function as assessed with the QuickDASH score over time.
transradial (TR)- and transfemoral (TF)-treated patients. Whiskers repre
(p < 0.05 was considered statistically signiﬁcant). A higher QuickDASH
extremity as assessed with the CISS (Cold Intolerance Symptom Severity
follow-up for TR- and TF-treated patients. Whiskers represent 5th to 9
considered statistically signiﬁcant).with a median score of 6.82 (IQR: 4.55 to 14.77). A
decrease was present in 105 patients (36.7%), with a
median score of 6.82 (IQR: 2.39 to 12.50). The Quick-
DASH score remained unchanged in 108 patients
(37.8%). If we applied an MCID of 14, 6.3% of the pa-
tients would have a clinically-relevant decrease of
upper extremity function, 7.7% would have an in-
crease, and 86.0% would have no clinical relevant
change at all. Figure 3B stratiﬁes the percentage of TF
patients with increased, decreased, or unchanged
QuickDASH scores. An increased QuickDASH score
was not associated with the applied access route,
irrespective of the implementation of MCID cut-off
values (for an MCID of 8: p ¼ 0.58; for an MCID of 14:
p ¼ 0.71; and if MCID is not applied: p ¼ 0.94).
A decrease of the QuickDASH score was also not
associated with the applied access route (p ¼ 0.62,
MCID not applied).
Cold intolerance was assessed with the CISS ques-
tionnaire. At baseline, signiﬁcantly higher CISS scores
were present in female patients (p < 0.001). The CISS
score was similar in both access groups (p ¼ 0.14) and
both age groups (elderly vs. non-elderly patients,
p ¼ 0.87). CISS scores did not change over time when
the procedure was performed through the radial
or femoral artery, as represented in Figure 2B.
The development of pathological cold intoleranceld Intolerance Stratiﬁed by Access Site
Box plots show the change of the QuickDASH score between baseline and 30-day follow-up for
sent 5th to 95th percentiles, and p values were calculated with Wilcoxon signed rank test
score indicates worse upper limb function or symptoms. (B) Cold intolerance of the upper
) score over time. Box plots show the change of the CISS score between baseline and 30-day
5th percentiles, and p values were calculated with Wilcoxon signed rank test (p < 0.05 was
FIGURE 3 Change of Upper Limb Function Stratiﬁed for Minimal Clinically Important Difference and Access Type
(A) Transradial access. The percentage of patients with increased, decreased, or unchanged QuickDASH scores stratiﬁed by the applied minimal clinically-important
difference (MCID). (B) Transfemoral access. The percentage of patients with increased, decreased, or unchanged QuickDASH scores stratiﬁed by the applied MCID.
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520(deﬁned as a CISS $30 [27]) was not associated with
the applied access route (p ¼ 0.71) and was present in
18 patients after TR access (6.3%) and 4 patients after
TF access (7.7%).
A lack of patent dual palmar arch circulation was
present in 8.0% of patients when assessed with
the Allen test and 6.2% when assessed with the Bar-
beau test. Inadequate post-procedural patency of the
radial artery was present in 6.4% of the patients, as
assessed with the reverse Barbeau test. No associa-
tion could be observed between abnormal vascular
communication or patency and the loss of upper ex-
tremity function (Allen test, p ¼ 0.99; Barbeau test,
p ¼ 0.88; reverse Barbeau test, p ¼ 0.99). The same
holds true for cold intolerance (Allen test, p ¼ 0.41;
Barbeau test, p ¼ 0.99; reverse Barbeau, p ¼ 0.35).FIGURE 4 Duration and Type of Upper Extremity Complaints After
(A) Procedure-related upper extremity complaints after transradial acces
temporary and persisting upper extremity complaints after transradial ac
persisted during 30-day follow-up after transradial access. A pie chart s
extremity complaints after transradial access.Procedure-related extremity problems were
equally reported by patients with TR and TF access
(19.6% vs. 17.3%, respectively; p ¼ 0.70). Extremity
problems that persisted during 30-day follow-up
were also not different between both access groups
(TR 10.5%, TF 11.5%; p ¼ 0.82). Figure 4 shows that
pain of the upper extremity was the most frequent
reported complaint after TR catheterization that
persisted during 30-day follow-up (4.5%).
DISCUSSION
The present study shows that TR access for per-
cutaneous coronary procedures does not affect
self-reported upper limb function. The mean pre-
procedural QuickDASH score was not different fromTR Access
s. A pie chart highlighting the numerical proportions of patients with
cess. (B) Type of procedure-related upper extremity complaints that
ummarizing the numerical proportions of different types of persisting
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521the score at 30-day follow-up. Although a proportion of
patients reported deterioration of upper limb function
after TR access, this was not numerically or statis-
tically different from patients with a transfemoral ac-
cess. Moreover, deterioration of upper limb function
will not be of clinical relevance in most instances.
Several outcome measures have been proposed to
assess upper limb disability (33). The Short Form
Health Survey is a generic questionnaire that is used
for evaluating health-related quality-of-life after PCI
and a variety of cardiovascular disorders (34). How-
ever, this questionnaire is less sensitive to clinical
change in patients with problems in a speciﬁc
anatomic region (35). The QuickDASH score has
proven to be a validated outcome measure to monitor
upper extremity disability for both clinical and
research purposes. This score, with good test-retest
reliability, is a reliable tool to assess difference over
time in a normative population (18) and a variable
number of upper extremity conditions (17). In the case
of TR catheterization, upper limb function was not
jeopardized. However, a trend toward a lower Quick-
DASH score was observed at follow-up, which might
be caused by response bias (36). Patients might report
less upper extremity symptoms at follow-up when
signiﬁcant coronary artery disease has been success-
fully treated by PCI. This may be supported by the
higher PCI rate (69.5%) in patients with decreased
QuickDASH scores, although statistical signiﬁcance
was not reached (p ¼ 0.054). The QuickDASH scores in
our study population were comparable to that of the
general population (37), with signiﬁcantly higher
scores in female and elderly patients (18,38).
The occurrence of cold intolerance was considered
to be a secondary outcome, because it is associated
with signiﬁcant functional impairment, and as many
as 85% of patients with all types of upper extremity
injuries complain of some degree of cold sensitivity
(25). Cold intolerance is mainly present when neuro-
vascular structures are involved, including those in-
juries caused by injection or puncture (25). However,
the estimated prevalence of cold intolerance greatly
depends on the method of measuring and deﬁning
cold intolerance, ranging from patient-mentioned
symptoms to validated questionnaires (24,27,39).
The current study used the validated CISS question-
naire (27) and detected no signiﬁcant change over
time when catheterization was performed through
the radial artery. As a reference group, we studied the
change of cold intolerance in patients with TF access,
which was unchanged as well. The baseline score for
cold intolerance was comparable with subjects in a
normative population. Further follow-up might be
needed, because the degree of cold sensitivityincreases until 3 months post-procedure and remains
constant thereafter (25).
The assessment of a patent dual palmar arch circu-
lation is recommended before every TR procedure
(40). The most-applied method of this assessment
used to be the Allen test; however, plethysmography
assessment (Barbeau test) appeared to be more sensi-
tive to evaluate the collateral supply (30). In clinical
practice, both tests are not routinely used (41), because
the predictive value for ischemic complications after
TR access is not clear. It has been demonstrated that
patients with an abnormal Allen test showed a signif-
icant increase in thumb capillary lactate (42). How-
ever, a recent publication of the RADAR (Should
Intervention Through Radial Approach be Denied to
Patients With Negative Allen’s Test Results?) study
group demonstrated that no clinical or subclinical sign
of hand ischemia was detected in patients with an
abnormal Allen test undergoing TR catheterization
(43). We observed 1 patient with a type D plethys-
mography test who underwent vascular surgery
because of radial artery occlusion with ischemic
symptoms. In our analysis, we could not ﬁnd a rela-
tionship between abnormal vascular communication
and the occurrence of upper extremity disability (p ¼
0.99). It was previously demonstrated that 50% to 60%
of all cases with RA occlusion become symptomatic (7),
although we could not ﬁnd a relation between
abnormal vascular patency of the RA and the occur-
rence of upper extremity disability (p ¼ 0.88). How-
ever, we did not conﬁrm every potential radial artery
occlusion with echo-duplex.
This is the ﬁrst study that investigated the effect of
TR access on upper extremity function. Although
previous studies have solely reported about upper
extremity problems, complications, and quality of
life, the primary focus in our study was to evaluate
upper extremity function. Despite the anatomic and
physiologic changes that are induced by radial access,
our study demonstrated that patients do not report a
signiﬁcant reduction of upper extremity function af-
ter TR catheterization.
STUDY LIMITATIONS. Cohort studies are vulnerable
to bias; however, the prospective paired design made
it less prone to bias with respect to the similarity of
external variables. Importantly, we were not able to
include all consecutive patients due to competing
studies and logistics. Questionnaire bias may affect
the outcome by the design of the questions and how
the questionnaires are administered or completed
(36). However, QuickDASH and CISS are both short
questionnaires that have been validated for several
injuries and in a normative population. We observed
PERSPECTIVES
WHAT’S KNOWN? Anatomic and physiological
changes that are induced by radial access might
jeopardize upper limb function. Although previous
studies have solely reported about upper extremity
problems, complications, and quality of life, the pri-
mary focus in our study was to evaluate the change of
upper extremity function after TR access as reported
by the patient.
WHAT’S NEW? This is the ﬁrst study that investi-
gated the effects of TR access on upper extremity
function as reported by the patient. The results of this
study are important to inform patients adequately
about the functional consequences of TR access,
especially when optimal upper extremity function
is essential.
WHAT’S NEXT? The assessment of patent dual
palmar arch circulation is recommended before TR
procedures. However, the clinical value of patency
tests is currently unclear, with controversial results
of thumb capillary lactate levels in patients with
abnormal Allen tests. Future research will be needed
to deﬁne the safety of TR access in patients with
abnormal dual arterial supply.
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522a good response rate and completion of the ques-
tionnaires, which supports the proper design of both
questionnaires.
Our study results may have been inﬂuenced by
response bias and additional treatment (PCI), as pre-
viously mentioned. Bias induced by the interviewer
with respect to the study hypothesis (“binding”) was
not applicable to our study results due to the self-
reported design. Unfortunately, we were not able to
relate upper extremity problems or functionality to
the incidence of RA occlusion at follow-up, because a
clinical follow-up visit was not mandatory in the
present study.
CONCLUSIONS
Our study demonstrated that self-reported upper
limb function was not jeopardized when coronary
catheterizations and interventions were performed
through the radial artery. The results of our study are
of importance to all patients undergoing TR access,
especially when optimal upper extremity function is
essential.
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